plasmodium vivax
Showing 1 - 7 of 7
The Malaria Heart Disease Study
Terminated
- Plasmodium Falciparum
- +3 more
- Assessment of cardiac function
-
Cruzeiro do Sul, Acre, BrazilPhilip Brainin
Jul 16, 2022
Plasmodium Vivax Trial in Vientiane (Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ), Dihydroartemisinin-piperaquine (DP)
Completed
- Plasmodium Vivax
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ)
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ) placebo
-
Vientiane, Lao People's Democratic RepublicLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
Feb 14, 2022
Malaria, Plasmodium Vivax Trial in Silver Spring (VMP001, P. vivax sporozoite challenge)
Completed
- Malaria
- Plasmodium Vivax
- VMP001
- P. vivax sporozoite challenge
-
Silver Spring, MarylandClinical Trials Center, Walter Reed Army Institute of Reserach
May 8, 2019
Malaria, Plasmodium Vivax Trial in Bangkok (Tafenoquine, Chloroquine + Primaquine, tafenoquine)
Terminated
- Malaria
- Plasmodium Vivax
- Tafenoquine
- +2 more
-
Bangkok, ThailandBangkok Hospital for Tropical Diseases/Mahidol University
Jan 29, 2018
Malaria, Plasmodium Vivax Trial in Oxford (ChAd63 PvDBP 5 x 10^9, ChAd63 PvDBP 5 x 10^10, MVA PvDBP 1 x 10^8)
Completed
- Malaria
- Plasmodium Vivax
- ChAd63 PvDBP 5 x 10^9
- +3 more
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
May 5, 2017
Plasmodium Vivax Trial in Madang (Primaquine)
Unknown status
- Plasmodium Vivax
-
Madang, Madang Province, Papua New GuineaPNG Institute of Medical Research
Oct 12, 2015